Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API
← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

60 ta ish

Ish: Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan–Korea Oncology Consortium

  1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

    Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4

    MaqolaGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 iqtibos
    ABI

  2. Cancer statistics for the year 2020: An overview

    Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram +4

    Maqola202110 iqtibos
    ABI

  3. EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

    Peter R. Galle, Alejandro Forner, Josep M. Llovet +5

    Sharh maqola20185 iqtibos
    ABI

  4. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013

    Aparna Schweitzer, Johannes Horn, Rafael Mikolajczyk +2

    Sharh maqola20154 iqtibos
    ABI

  5. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

    Rafael Lozano, Mohsen Naghavi, Kyle J Foreman +97

    Maqola20124 iqtibos
    ABI

  6. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies

    Sarah C. Darby, David Hill, Anssi Auvinen +23

    Maqola20043 iqtibos
    ABI

  7. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial

    Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong +21

    Maqola20203 iqtibos
    ABI

  8. Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

    Mei‐Hwei Chang, San‐Lin You, Chien‐Jen Chen +9

    Maqola20092 iqtibos
    ABI

  9. Sorafenib in Advanced Hepatocellular Carcinoma

    Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro +21

    Maqola20082 iqtibos
    ABI

  10. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

    Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen +18

    Maqola20082 iqtibos
    ABI

  11. Global epidemiology and genotype distribution of the hepatitis C virus infection

    E. Gower, Chris Estes, Sarah Blach +2

    Sharh maqola20142 iqtibos
    ABI

  12. A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.

    Masatoshi Kudo

    Tahririyat maqolasi20172 iqtibos
    ABI

  13. Aflatoxin B<sub>1</sub> exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers

    Yu‐Ju Chu, Hwai‐I Yang, Hui‐Chen Wu +8

    Maqola20172 iqtibos
    ABI

  14. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  15. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  16. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  17. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  18. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  19. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  20. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  21. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  22. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  23. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  24. Sarlavhasiz

    Boshqa1 iqtibos
    ABI

  25. Sarlavhasiz

    Boshqa1 iqtibos
    ABI